US Markets in:
hrs
min
sec
Set StockTrendNews.com as your Homepage! -
Click Here
Home
About Us
Subscribe
Contact
StockTrendNews (STN) Exclusive:
Celsion Corporation
Enter Symbol or Keywords
x
Celsion's Cash Flow from Operations Increases 47%
Stock Quote:
(NGM:CLSN)
11/18/2009
4.55
+0.30
+7.06%
95,716
Celsion's Cash Flow from Operations Increases 47%
Last
Price Change
% Chg
Volume
New York, NY, November 18, 2009-CFFO-NEWS reports that Cash Flow from Operations (CFFO) for Celsion Corporation (NASDAQ:CLSN) for its quarter ended September 30, 2009 was $(5,055,863), a 47% deteriora
... read full story
Website Address:
www.celsion.com
Industry:
Minimally Invasive Medical Devices
Most Recent STN Exclusives
x
03/19/2010
T12-NEWS reports that the MedClean's Revenue for its 3 months ended December 31, 2009 Increased by 52.47%
03/19/2010
Ten Year High in EBITDA for BlackRock
03/19/2010
EBITDA Increases 109% for Agilent
03/19/2010
Western Refining's EBITDA Turns Negative for its Twelve Months
03/19/2010
Two Year High in Cash Flow from Operations for Smithfield Foods
03/19/2010
Vina Concha y Toro's Free Cash Flow Turns Positive for its Twelve Months
03/19/2010
OPS Ranking of "2" Reiteration for STMicroelectronics
03/19/2010
EBITDA for Smucker Reaches Fourteen Year High
03/19/2010
EBITDA for Liberty Acquisition Deteriorates more than 1,000%
03/19/2010
StockDiagnostics.com Reiterates Quiksilver's OPS Ranking of "1"
Interactive Chart:
CLSN
x
Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now
More STN Exclusives for:
CLSN
x
11/20/2009
EBITDA for Celsion Reaches Twelve Year Low
11/18/2009
Celsion's OPS Ranking of "4" Reiterated by StockDiagnostics.com
11/18/2009
Celsion's Free Cash Flow Increases 45%
... more CLSN exclusives
Other News Sources:
CLSN
x
03/18/2010
Celsion Corporation Announces ThermoDox(R) Abstract Accepted for Presentation at the American Society of Clinical Oncology 2010 Annual Meeting
03/09/2010
Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application
03/01/2010
Celsion Plans to Launch Phase II Program to Study ThermoDox(R) in Combination with RFA for Colorectal Liver Metastases
... more CLSN news from other sources
Daily Market Updates
x
03/19/2010
Stocks Break Eight-Day Winning Streak and End With Losses
Despite a quadruple witching day" today
... read full story
Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com
x
follow STN on Twitter
x
©2010 StockTrendNews.com
Disclaimer
Terms of Sales
Privacy
About Us
+0.30 
